Nasal Polyps clinical trials at University of California Health

2 in progress, 1 open to eligible people

Showing trials for

  • Tissue Immune Interaction in Nasal Polyposis

    open to eligible people ages 18-80

    This is a cross-sectional study of up to 100 subjects who are undergoing clinically indicated sinus procedures to treat chronic rhinosinusitis. Participants will be asked to donate leftover sino-nasal secretions, sino-nasal tissue and blood as well as undergo partial characterization. As optional extensions of the main study, participants may also undergo a biopsy of extra sino-nasal tissue for additional tissue analysis and/or a more detailed characterization visit performed in the UCSF Airway Center Research Center (ACRC).

    at UCSF

  • Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

    Sorry, not currently recruiting here

    The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with chronic rhinosinusitis and nasal polyps treated with intranasal corticosteroids. The study will last about 18 months.

    at UC Irvine

Our lead scientists for Nasal Polyps research studies include .

Last updated: